183 related articles for article (PubMed ID: 16253762)
21. Increasing the effectiveness of radioactive iodine therapy in the treatment of thyroid cancer using Trichostatin A, a histone deacetylase inhibitor.
Zarnegar R; Brunaud L; Kanauchi H; Wong M; Fung M; Ginzinger D; Duh QY; Clark OH
Surgery; 2002 Dec; 132(6):984-90; discussion 990. PubMed ID: 12490845
[TBL] [Abstract][Full Text] [Related]
22. Experimental targeted radioiodide therapy following transfection of the sodium iodide symporter gene: effect on clonogenicity in both two-and three-dimensional models.
Carlin S; Cunningham SH; Boyd M; McCluskey AG; Mairs RJ
Cancer Gene Ther; 2000 Dec; 7(12):1529-36. PubMed ID: 11228531
[TBL] [Abstract][Full Text] [Related]
23. The Na+/I- symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid.
Wapnir IL; Goris M; Yudd A; Dohan O; Adelman D; Nowels K; Carrasco N
Clin Cancer Res; 2004 Jul; 10(13):4294-302. PubMed ID: 15240514
[TBL] [Abstract][Full Text] [Related]
24. Combination therapy and noninvasive imaging with a dual therapeutic vector expressing MDR1 short hairpin RNA and a sodium iodide symporter.
Park SY; Kwak W; Thapa N; Jung MY; Nam JO; So IS; Kim SY; Yoo J; Lee J; Kim IS
J Nucl Med; 2008 Sep; 49(9):1480-8. PubMed ID: 18703598
[TBL] [Abstract][Full Text] [Related]
25. Targeted radioiodine therapy of neuroblastoma tumors following systemic nonviral delivery of the sodium iodide symporter gene.
Klutz K; Russ V; Willhauck MJ; Wunderlich N; Zach C; Gildehaus FJ; Göke B; Wagner E; Ogris M; Spitzweg C
Clin Cancer Res; 2009 Oct; 15(19):6079-86. PubMed ID: 19789324
[TBL] [Abstract][Full Text] [Related]
26. Endogenous thyrocyte-produced nitric oxide inhibits iodide uptake and thyroid-specific gene expression in FRTL-5 thyroid cells.
Fozzatti L; Vélez ML; Lucero AM; Nicola JP; Mascanfroni ID; Macció DR; Pellizas CG; Roth GA; Masini-Repiso AM
J Endocrinol; 2007 Mar; 192(3):627-37. PubMed ID: 17332530
[TBL] [Abstract][Full Text] [Related]
27. Regulation of sodium-iodide-symporter gene expression in human thyrocytes measured by real-time polymerase chain reaction.
Wagner S; Aust G; Schott M; Scherbaum WA; Feldkamp J; Seissler J
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):398-402. PubMed ID: 12518250
[TBL] [Abstract][Full Text] [Related]
28. Histidine residue at position 226 is critical for iodide uptake activity of human sodium/iodide symporter.
Wu SL; Ho TY; Liang JA; Hsiang CY
J Endocrinol; 2008 Nov; 199(2):213-9. PubMed ID: 18708479
[TBL] [Abstract][Full Text] [Related]
29. Doxorubicin enhances the expression of transgene under control of the CMV promoter in anaplastic thyroid carcinoma cells.
Kim KI; Kang JH; Chung JK; Lee YJ; Jeong JM; Lee DS; Lee MC
J Nucl Med; 2007 Sep; 48(9):1553-61. PubMed ID: 17704247
[TBL] [Abstract][Full Text] [Related]
30. Radioiodide uptake and sodium iodide symporter expression in breast carcinoma.
Damle AA; Narkar AA; Badwe RA
Indian J Exp Biol; 2011 Jun; 49(6):416-22. PubMed ID: 21702220
[TBL] [Abstract][Full Text] [Related]
31. Radioiodine therapy of hepatoma using targeted transfer of the human sodium/iodide symporter gene.
Chen L; Altmann A; Mier W; Eskerski H; Leotta K; Guo L; Zhu R; Haberkorn U
J Nucl Med; 2006 May; 47(5):854-62. PubMed ID: 16644756
[TBL] [Abstract][Full Text] [Related]
32. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.
De La Vieja A; Ginter CS; Carrasco N
J Cell Sci; 2004 Feb; 117(Pt 5):677-87. PubMed ID: 14734652
[TBL] [Abstract][Full Text] [Related]
33. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
[TBL] [Abstract][Full Text] [Related]
34. Methylation status of genes in papillary thyroid carcinoma.
Smith JA; Fan CY; Zou C; Bodenner D; Kokoska MS
Arch Otolaryngol Head Neck Surg; 2007 Oct; 133(10):1006-11. PubMed ID: 17938324
[TBL] [Abstract][Full Text] [Related]
35. Enhanced expression of adenovirus-mediated sodium iodide symporter gene in MCF-7 breast cancer cells with retinoic acid treatment.
Lim SJ; Paeng JC; Kim SJ; Kim SY; Lee H; Moon DH
J Nucl Med; 2007 Mar; 48(3):398-404. PubMed ID: 17332617
[TBL] [Abstract][Full Text] [Related]
36. Iodination of proteins in TPO transfected thyroid cancer cells is independent of NIS.
Wenzel A; Upadhyay G; Schmitt TL; Loos U
Mol Cell Endocrinol; 2003 Dec; 213(1):99-108. PubMed ID: 15062578
[TBL] [Abstract][Full Text] [Related]
37. Sodium iodide symporter: its role in nuclear medicine.
Chung JK
J Nucl Med; 2002 Sep; 43(9):1188-200. PubMed ID: 12215558
[TBL] [Abstract][Full Text] [Related]
38. Retinoic acid and tributyrin induce in-vitro radioiodine uptake and inhibition of cell proliferation in a poorly differentiated follicular thyroid carcinoma.
Zhang M; Guo R; Xu H; Zhang M; Li B
Nucl Med Commun; 2011 Jul; 32(7):605-10. PubMed ID: 21471848
[TBL] [Abstract][Full Text] [Related]
39. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose.
Haberkorn U; Kinscherf R; Kissel M; Kübler W; Mahmut M; Sieger S; Eisenhut M; Peschke P; Altmann A
Gene Ther; 2003 May; 10(9):774-80. PubMed ID: 12704416
[TBL] [Abstract][Full Text] [Related]
40. Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas.
Russo D; Manole D; Arturi F; Suarez HG; Schlumberger M; Filetti S; Derwahl M
Thyroid; 2001 Jan; 11(1):37-9. PubMed ID: 11272095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
